https://www.has-sante.fr/jcms/p_3517015/fr/fabhalta-iptacopan-hemoglobinurie-paroxystique-nocturne 2024 false false false France iptacopan treatment outcome insurance, health, reimbursement paroxysmal nocturnal hemoglobinuria hemoglobinuria, paroxysmal adult guidelines for drug use administration, oral complement inactivating agents orphan drug production anemia, hemolytic Iptacopan Hydrochloride evaluation of the transparency committee Iptacopan